title: Spatial contrast sensitivity in benign intracranial hypertension.
abstract: Spatial Contrast Sensitivity (CS) was studied in 20 patients with benign intracranial hypertension (BIH). At presentation CS loss was found in 43% of the eyes, and impairment of visual acuity attributed to BIH in only 16%. Nine patients had blurred vision or visual obscurations, all of whom had abnormal CS. The clinical application of CS measurement in BIH for monitoring the progression or regression of the disease is illustrated by serial measurements in 11 patients. Progressive visual loss in longstanding papilloedema and improvement of visual function in subsiding papilloedema can occur without any change in Snellen acuity or visual field charting.
authors.affiliation: Department of Neurology, Sint Franciscus Gasthuis Rotterdam, The Netherlands.
authors.forename: C
authors.initials: C
authors.lastname: Bulens
authors.forename: J D
authors.initials: JD
authors.lastname: Meerwaldt
authors.forename: P J
authors.initials: PJ
authors.lastname: Koudstaal
authors.forename: G J
authors.initials: GJ
authors.lastname: Van der Wildt
mesh_terms: D000293:Adolescent; D000328:Adult; D004193:Discrimination Learning / Q000502:physiology; D005260:Female; D005556:Form Perception / Q000502:physiology*; D006801:Humans; D007427:Intracranial Pressure; D008297:Male; D008875:Middle Aged; D009949:Orientation / Q000502:physiology*; D010211:Papilledema / Q000503:physiopathology; D010364:Pattern Recognition, Visual / Q000502:physiology*; D011559:Pseudotumor Cerebri / Q000503:physiopathology*; D013028:Space Perception / Q000502:physiology*; D014786:Vision Disorders / Q000503:physiopathology; D014792:Visual Acuity; D014794:Visual Fields